|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Data complement anti-STD activity of PRO 2000 gel. Contraceptives. |
| AIDS WEEKLY PLUS. 1997 May 19;:15. |
| Procept, Cambridge, Massachusetts, announced preclinical results demonstrating the contraceptive efficacy of its |
| PRO 2000 topical microbicide gel. In a program of late-breaking discoveries presented at the National Conference |
| on Women and HIV, held in Pasadena, California, Procept scientists described the results of studies recently |
| conducted with PRO 2000. The in vitro results showed that PRO 2000 was contraceptive when rabbits were dosed |
| intravaginally with a gel containing a 4% concentration of PRO 2000. At a concentration about 10 times lower, PRO |
| 2000 did not appear to affect the rabbit pregnancy rate. Results of preclinical tests have indicated that both |
| concentrations prevent HIV infection, suggesting that contraceptive and noncontraceptive formulations of this drug |
| may be developed. "The potential of this compound as an advancement in the area of women's health is significant," |
| said Stanley C. Erck, Procept. "We believe that the contraceptive properties demonstrated by PRO 2000 Gel will |
| complement the anti-HIV/STD activity we will be evaluating in clinical trials." "More than 70% of all HIV infections |
| worldwide follow heterosexual intercourse. A major problem confounding efforts to prevent AIDS in women has been |
| the lack of effective, female-controlled barrier methods. PRO 2000 Gel has been identified as a topical microbicide |
| well suited for use by women to prevent HIV infection. In laboratory studies, PRO 2000 blocked infection by a wide |
| variety of HIV strains and also was active against herpes simplex virus." Clinical studies currently are underway to |
| assess the safety of PRO 2000 Gel in healthy female volunteers. Assuming the results of these studies are positive, |
| additional studies will be conducted to demonstrate safety and efficacy in populations at high risk for HIV infection. |
| (PubHealth.info Document ID: CONT2T 532-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Data complement anti-STD activity of PRO 2000 gel. |
| Contraceptives.", is(are) . The source of this article is "AIDS WEEKLY PLUS. 1997 May 19;:15.". This article was |
| published in 1997 in English language(s). (PubHealth.info® Document ID: CONT2T 532-06. All rights reserved with |
| PubHealth.info) PIN: 5532 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |
